CorMedix Inc — Balance Sheet (NASDAQ:CRMD) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Total assets 49.31 M68.95 M62.04 M82.06 M118.85 M Total liabilities 5.09 M6.15 M6.98 M11.92 M34.19 M Total equity 44.22 M62.8 M55.06 M70.14 M84.66 M Total liabilities & shareholders' equities 49.31 M68.95 M62.04 M82.06 M118.85 M Total debt ————— Net debt —————

Новости

Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?

Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?

CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?

CorMedix Inc. (CRMD) Analyst/Investor Day Transcript

CorMedix Inc. (CRMD) Analyst/Investor Day - Slideshow (NASDAQ:CRMD) 2026-02-11

Citizens подтверждает рейтинг Market Outperform для акций CorMedix

CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside

Акции CorMedix растут после объявления о выкупе акций на $75 млн

CorMedix stock rises after announcing $75 million share buyback plan

CorMedix объявляет о программе обратного выкупа акций на $75 млн

CorMedix announces $75 million share repurchase program